German chemical firms report improved 1Q figures
Germany's chemical companies have reported improved sales and earnings in the first quarter of the year, and are optimistic of an improved operating environment through 2005, reports Phil Taylor.
Archives for May 3, 2005
Charles River 1Q reflects outsourcing trend
Charles River Laboratories saw a double-digit boost in fiscal first quarter revenues reflecting a jump in operating earnings, helped by its acquisition of Inveresk Research Group and the emerging trend in outsourcing preclinical services.
Bio-Tek and LI-COR strike microplate stacker deal
Bio-Tek Instruments and LI-COR Biosciences announce the integration of Bio-Tek's Bio-Stack Microplate Stacker to LI-COR's new Aerius Automated Infrared Imaging System, a microplate reader providing automated data analysis of In-Cell Westerns.
Non-injectable insulin debuts in Ecuador
Canadian company Generex Biotechnology has stolen a march on its larger rivals in the pharmaceutical industry by winning regulatory approval for the world's first non-injectable insulin formulation, reports Phil Taylor.
PANalytical opens Chinese laboratory
PANalytical, a supplier of analytical instrumentation and software for X-ray diffraction and X-ray fluorescence spectrometry, has expanded ibnto Asia with the opening of a Regional Application Laboratory in Shanghai, China.
Teva swings to profit in first quarter
Teva Pharmaceutical Industries' active pharmaceutical ingredients (API) business is on track to become a $1 billion enterprise this year, although growth in the first quarter of this year was almost entirely from in-house sales, reports Phil Taylor.